South Africa’s Department of Health says the country is preparing for possible access to a new tuberculosis (TB) vaccine, contingent on results from ongoing late-stage testing. The department welcomes reported progress in the development of the vaccine, noting that it is backed by the Bill and Melinda Gates Foundation. South Africa indicates it is monitoring a phase three trial process, which is designed to test the vaccine’s safety and effectiveness in broader populations. The department frames its preparations as a response plan in case the vaccine meets required outcomes and becomes available. While the announcement focuses on the likelihood of future access rather than any confirmed rollout, it highlights the government’s readiness to consider adoption once clinical trial findings are reviewed. Overall, the information points to continued advancement in TB vaccine research and South Africa’s intention to be positioned for the next step should the phase three results be positive.